Cardiomyopathy in cirrhosis: From pathophysiology to clinical care

Izzy, 2020, Redefining cirrhotic cardiomyopathy for the modern era, Hepatology, 71, 334, 10.1002/hep.30875 Yoon, 2020, Cirrhotic cardiomyopathy, Curr Gastroenterol Rep, 22, 45, 10.1007/s11894-020-00783-1 Liu, 2022, Pathogenic mechanisms underlying cirrhotic cardiomyopathy, Front Netw Physiol, 2, 849253, 10.3389/fnetp.2022.849253 Liu, 2021, Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling, Front Cell Dev Biol, 23 Gaskari, 2015, Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids, J Hepatol, 62, 1272, 10.1016/j.jhep.2015.01.021 Zuo, 2018, Acute administration of tumour necrosis factor-alpha induces spontaneous calcium release via the reactive oxygen species pathway in atrial myocytes, Europace, 20, 1367, 10.1093/europace/eux271 Kao, 2010, Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes, Crit Care Med, 38, 217, 10.1097/CCM.0b013e3181b4a854 Rao, 2016, Role of tumour necrosis factor-a in the regulation of T-type calcium channel current in HL-1 cells, Clin Exp Pharmacol Physiol, 43, 706, 10.1111/1440-1681.12585 Gregolin, 2021, Myocardial dysfunction in cirrhotic cardiomyopathy is associated with alterations of phospholamban phosphorylation and IL-6 levels, Arch Med Res, 52, 284, 10.1016/j.arcmed.2020.11.004 Lee, 1990, Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats, Hepatology, 12, 481, 10.1002/hep.1840120306 Ma, 2022, Role of anti-beta-1-adrenergic receptor antibodies in cardiac dysfunction in patients with cirrhotic cardiomyopathy, J Cardiovasc Transl Res, 15, 381, 10.1007/s12265-021-10161-5 Moller, 2018, Cirrhotic cardiomyopathy, J Hepatol, 69, 958, 10.1016/j.jhep.2018.01.006 Mashford, 1962, Studies of the cardiovascular system in the hypotension of liver failure, N Engl J Med, 267, 1071, 10.1056/NEJM196211222672105 Kellermayer, 2019, Titin mutations and muscle disease, Pflugers Arch, 471, 673, 10.1007/s00424-019-02272-5 Tharp, 2019, The giant protein titin’s role in cardiomyopathy: genetic, transcriptional, and post-translational modifications of TTN and their contribution to cardiac disease, Front Physiol, 10, 1436, 10.3389/fphys.2019.01436 Nagueh, 2004, Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy, Circulation, 110, 155, 10.1161/01.CIR.0000135591.37759.AF Glenn, 2011, Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats, J Hepatol, 55, 1249, 10.1016/j.jhep.2011.02.030 Honar, 2020, Impaired myosin isoform shift and calcium transients contribute to cellular pathogenesis of rat cirrhotic cardiomyopathy, Liver Int, 40, 2808, 10.1111/liv.14599 Liu, 2021, Advances in cirrhotic cardiomyopathy, Curr Opin Gastroenterol, 37, 187, 10.1097/MOG.0000000000000733 Ma, 1994, Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats, Am J Physiol, 267, G87 Ma, 1997, Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy, J Hepatol, 26, 904, 10.1016/S0168-8278(97)80259-0 Yoon, 2022, Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats, Clin Mol Hepatol, 28, 232, 10.3350/cmh.2021.0141 Izzy, 2021, Cirrhotic cardiomyopathy predicts posttransplant cardiovascular disease: revelations of the new diagnostic criteria, Liver Transpl, 27, 876, 10.1002/lt.26000 Cesari, 2021, Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification, Clin Exp Hepatol, 7, 270, 10.5114/ceh.2021.108708 Singh, 2022, Impact of cirrhotic cardiomyopathy diagnosed according to different criteria on patients with cirrhosis awaiting liver transplantation: a retrospective cohort study, Dig Dis Sci, 67, 5315, 10.1007/s10620-022-07412-z Rimbas, 2020, Cirrhotic cardiomyopathy in the era of liver transplantation: time for precise stepwise evaluation, J Gastrointestin Liver Dis, 29, 665, 10.15403/jgld-3137 Kwon, 2020, Appraisal of cardiac ejection fraction with liver disease severity: implication in post-liver transplantation mortality, Hepatology, 71, 1364, 10.1002/hep.30913 Smiseth, 2016, Myocardial strain imaging: how useful is it in clinical decision making?, Eur Heart J, 37, 1196, 10.1093/eurheartj/ehv529 Sengupta, 2013, Early impairment of left ventricular function in patients with systemic hypertension: new insights with 2-dimensional speckle tracking echocardiography, Indian Heart J, 65, 48, 10.1016/j.ihj.2012.12.009 Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines, J Am Coll Cardiol, 62, e147, 10.1016/j.jacc.2013.05.019 Hammami, 2017, Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?, Libyan J Med, 12, 10.1080/19932820.2017.1283162 Novo, 2018, Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study, Aliment Pharmacol Ther, 48, 740, 10.1111/apt.14934 Sampaio, 2013, Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study, Liver Int, 33, 1158, 10.1111/liv.12187 Rimbas, 2018, New definition criteria of myocardial dysfunction in patients with liver cirrhosis: a speckle tracking and tissue Doppler imaging study, Ultrasound Med Biol, 44, 562, 10.1016/j.ultrasmedbio.2017.11.013 Zamirian, 2019, Reduced myocardial reserve in cirrhotic patients: an evaluation by dobutamine stress speckle tracking and tissue Doppler imaging (TDI) echocardiography, J Cardiovasc Thorac Res, 11, 127, 10.15171/jcvtr.2019.22 Nafati, 2018, Use of speckle-tracking strain in preload-dependent patients, need for cautious interpretation, Ann Intensive Care, 8, 29, 10.1186/s13613-018-0376-8 Mechelinck, 2020, Global longitudinal strain at rest as an independent predictor of mortality in liver transplant candidates: a retrospective clinical study, J Clin Med, 9, 10.3390/jcm9082616 Kim, 2020, Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study, J Cardiovasc Magn Reson, 22, 25, 10.1186/s12968-020-00622-2 Chen, 2016, A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation, J Cardiol, 67, 140, 10.1016/j.jjcc.2015.08.001 Nagueh, 2016, Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging, J Am Soc Echocardiogr, 29, 277, 10.1016/j.echo.2016.01.011 Spann, 2022, Cirrhotic cardiomyopathy: appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes, Liver Transpl, 28, 1321, 10.1002/lt.26460 Santos, 2015, E/e’ Ratio in Patients With Unexplained Dyspnea: lack of Accuracy in Estimating Left Ventricular Filling Pressure, Circ Heart Fail, 8, 749, 10.1161/CIRCHEARTFAILURE.115.002161 Pieske, 2019, How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), Eur Heart J, 40, 3297, 10.1093/eurheartj/ehz641 Dowsley, 2012, Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation, Transplantation, 94, 646, 10.1097/TP.0b013e31825f0f97 Wong, 2001, The cardiac response to exercise in cirrhosis, Gut, 49, 268, 10.1136/gut.49.2.268 Chayanupatkul, 2014, Cirrhotic cardiomyopathy: review of pathophysiology and treatment, Hepatol Int, 8, 308, 10.1007/s12072-014-9531-y Dimitroglou, 2019, Cardiac imaging in liver transplantation candidates: current knowledge and future perspectives, J Clin Med, 8, 10.3390/jcm8122132 Chamsi-Pasha, 2020, CMR in the evaluation of diastolic dysfunction and phenotyping of HFpEF: current role and future perspectives, JACC Cardiovasc Imaging, 13, 283, 10.1016/j.jcmg.2019.02.031 Charoenpanichkit, 2010, The 20 year evolution of dobutamine stress cardiovascular magnetic resonance, J Cardiovasc Magn Reson, 12, 59, 10.1186/1532-429X-12-59 Satoh, 2014, Distribution of late gadolinium enhancement in various types of cardiomyopathies: significance in differential diagnosis, clinical features and prognosis, World J Cardiol, 6, 585, 10.4330/wjc.v6.i7.585 American College of Cardiology Foundation Task Force on Expert Consensus, 2010, ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American college of Cardiology foundation task force on expert consensus documents, J Am Coll Cardiol, 55, 2614, 10.1016/j.jacc.2009.11.011 Flett, 2010, Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans, Circulation, 122, 138, 10.1161/CIRCULATIONAHA.109.930636 Yang, 2019, Myocardial extracellular volume fraction adds prognostic information beyond myocardial replacement fibrosis, Circ Cardiovasc Imaging, 12, 10.1161/CIRCIMAGING.119.009535 Wiese, 2018, Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome, Liver Int, 38, 1614, 10.1111/liv.13870 Carpenter, 2011, On T2∗ magnetic resonance and cardiac iron, Circulation, 123, 1519, 10.1161/CIRCULATIONAHA.110.007641 O’Glasser, 2010, Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation, Clin Transpl, 24, 643, 10.1111/j.1399-0012.2009.01136.x Papadodima, 2019, Cardiac iron overload following liver transplantation in patients without hereditary hemochromatosis or severe hepatic iron deposition, Cardiovasc Pathol, 40, 7, 10.1016/j.carpath.2018.12.008 Abu Rajab, 2014, Iron overload secondary to cirrhosis: a mimic of hereditary haemochromatosis?, Histopathology, 65, 561, 10.1111/his.12417 Lewin, 2018, Cardiac MRI T2∗ in liver transplant candidates: application and performance of a novel imaging technique to identify patients at risk for poor posttransplant cardiac outcomes, Transpl Direct, 4, e363, 10.1097/TXD.0000000000000803 Liu, 2017, Cirrhotic cardiomyopathy: implications for liver transplantation, Liver Transpl, 23, 826, 10.1002/lt.24768 Razpotnik, 2021, The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria, Liver Int, 41, 1058, 10.1111/liv.14769 Arman, 2022, Cirrhotic cardiomyopathy per 2005 criteria is more common and less reversible than cirrhotic cardiomyopathy per 2019 criteria, Hepatoloty, 76, s514 2020, Correction, Hepatology, 72, 1161, 10.1002/hep.31463 Liu, 2021, Diagnostic criteria of cirrhotic cardiomyopathy: out with the old, in with the new?, Hepatology, 74, 3523, 10.1002/hep.32021 Glowczynska, 2022, Chronotropic incompetence in end-stage liver disease, PLoS One, 17, 10.1371/journal.pone.0270784 Zambruni, 2007, QT interval correction in patients with cirrhosis, J Cardiovasc Electrophysiol, 18, 77, 10.1111/j.1540-8167.2006.00622.x Bernardi, 1998, Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors, Hepatology, 27, 28, 10.1002/hep.510270106 Henriksen, 2007, Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate, Scand J Clin Lab Invest, 67, 643, 10.1080/00365510601182634 Tsiompanidis, 2018, Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity, World J Gastrointest Pathophysiol, 9, 28, 10.4291/wjgp.v9.i1.28 Ward, 1997, Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis, Am J Physiol, 273, G537 Kim, 2017, QT prolongation is associated with increased mortality in end stage liver disease, World J Cardiol, 9, 347, 10.4330/wjc.v9.i4.347 Li, 2021, Prolonged QTc interval predicts long-term mortality in cirrhosis: a propensity score matching analysis, Scand J Gastroenterol, 56, 570, 10.1080/00365521.2021.1901307 Ruiz-del-Arbol, 2013, Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine, Hepatology, 58, 1732, 10.1002/hep.26509 Ruiz-del-Arbol, 2005, Circulatory function and hepatorenal syndrome in cirrhosis, Hepatology, 42, 439, 10.1002/hep.20766 Krag, 2010, Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites, Gut, 59, 105, 10.1136/gut.2009.180570 Rabie, 2009, The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt, Am J Gastroenterol, 104, 2458, 10.1038/ajg.2009.321 Cazzaniga, 2007, Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt, Gut, 56, 869, 10.1136/gut.2006.102467 Giannelli, 2020, Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation, J Hepatol, 72, 463, 10.1016/j.jhep.2019.10.002 Altieri, 2022, Cardiovascular events after liver transplantation: MACE hurts, Rev Cardiovasc Med, 23, 91, 10.31083/j.rcm2303091 Gurram, 2022, Predicting cardiovascular complications after liver transplantation, 327 Sheibani, 2020, Protective effects of spermidine against cirrhotic cardiomyopathy in bile duct-ligated rats, J Cardiovasc Pharmacol, 76, 286, 10.1097/FJC.0000000000000872 Niaz, 2022, Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats, Life Sci, 308, 120966, 10.1016/j.lfs.2022.120966 Bortoluzzi, 2013, Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms, Hepatology, 57, 266, 10.1002/hep.26021 Mousavi, 2020, Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms, Clin Exp Hepatol, 6, 207, 10.5114/ceh.2020.99513 de Souza, 2021, Exercise training attenuates cirrhotic cardiomyopathy, J Cardiovasc Transl Res, 14, 674, 10.1007/s12265-020-09997-0 La Mura, 2013, Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction, Hepatology, 57, 1172, 10.1002/hep.26127 Marrone, 2015, KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins, Gut, 64, 1434, 10.1136/gutjnl-2014-308338 Pose, 2019, Statins: old drugs as new therapy for liver diseases?, J Hepatol, 70, 194, 10.1016/j.jhep.2018.07.019 Hothersall, 2006, Potential therapeutic role for statins in respiratory disease, Thorax, 61, 729, 10.1136/thx.2005.057976 Yang, 2010, Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids, J Hepatol, 53, 298, 10.1016/j.jhep.2010.03.011 Wong, 2022, Albumin therapy for hepatic encephalopathy: current evidence and controversies, Metab Brain Dis Desai, 2017, Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart, Hepatology, 65, 189, 10.1002/hep.28890 Liu, 2020, Taurine protects against cardiac dysfunction induced by pressure overload through SIRT1-p53 activation, Chem Biol Interact, 317, 10.1016/j.cbi.2020.108972 Nam, 2014, Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice, Clin Sci (Lond), 127, 519, 10.1042/CS20130642 Inserte, 2003, Left ventricular hypertrophy in rats with biliary cirrhosis, Hepatology, 38, 589, 10.1053/jhep.2003.50369 Bayat, 2022, Silymarin administration attenuates cirrhotic-induced cardiac abnormality in the rats: a possible role of beta1-adrenergic receptors and L-type voltage-dependent calcium channels, Iran J Med Sci, 47, 367 Wanninger, 2011, Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function, Cytokine, 55, 435, 10.1016/j.cyto.2011.06.001 Shah, 2010, Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure, Eur J Heart Fail, 12, 826, 10.1093/eurjhf/hfq091 Weir, 2013, Galectin-3 and cardiac function in survivors of acute myocardial infarction, Circ Heart Fail, 6, 492, 10.1161/CIRCHEARTFAILURE.112.000146 van Kimmenade, 2006, Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure, J Am Coll Cardiol, 48, 1217, 10.1016/j.jacc.2006.03.061 Sharma, 2004, Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction, Circulation, 110, 3121, 10.1161/01.CIR.0000147181.65298.4D Souza, 2017, Association of cardiac galectin-3 expression, myocarditis, and fibrosis in chronic chagas disease cardiomyopathy, Am J Pathol, 187, 1134, 10.1016/j.ajpath.2017.01.016 Yu, 2013, Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis, Circ Heart Fail, 6, 107, 10.1161/CIRCHEARTFAILURE.112.971168 Zheng, 2022, Effects of high-intensity and moderate-intensity exercise training on cardiopulmonary function in patients with coronary artery disease: a meta-analysis, Front Cardiovasc Med, 9, 10.3389/fcvm.2022.961414 Chahal, 2021, Review article: comprehensive analysis of cirrhotic cardiomyopathy, Aliment Pharmacol Ther, 53, 985, 10.1111/apt.16305 Bodys-Pelka, 2021, What’s new in cirrhotic cardiomyopathy?-review article, J Pers Med, 11 Yoon, 2021, beta-blockers in advanced cirrhosis: more friend than enemy, Clin Mol Hepatol, 27, 425, 10.3350/cmh.2020.0234 Silvestre, 2018, beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial, Eur J Gastroenterol Hepatol, 30, 930, 10.1097/MEG.0000000000001128 Alvarado-Tapias, 2020, Short-term hemodynamic effects of beta-blockers influence survival of patients with decompensated cirrhosis, J Hepatol, 73, 829, 10.1016/j.jhep.2020.03.048 Krag, 2012, The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease, Gut, 61, 967, 10.1136/gutjnl-2011-301348 Fukuta, 2019, Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials, Heart Fail Rev, 24, 535, 10.1007/s10741-019-09774-5 Blumenthal, 2012, Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial, JAMA, 308, 465, 10.1001/jama.2012.8720 Yuan, 2019, Cardiac health in patients with hepatitis B virus-related cirrhosis, Medicine (Baltimore), 98 Mookerjee, 2016, Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure, J Hepatol, 64, 574, 10.1016/j.jhep.2015.10.018 Lee, 2022, Prolonged QT interval in cirrhosis: twisting time?, Gut Liver, 16, 849, 10.5009/gnl210537 Vink, 2018, Determination and interpretation of the QT interval, Circulation, 138, 2345, 10.1161/CIRCULATIONAHA.118.033943 Albillos, 2023, Beta-blockers in the era of precision medicine in patients with cirrhosis, J Hepatol, 78, 866, 10.1016/j.jhep.2022.12.005